The brokerage firm Motilal Oswal gave a ‘Buy’ rating to these four stocks today. From HCL Technologies to IIFL Finance read about all four stocks that Motilal Oswal is betting on and the key reasons driving the recommendation-
HCL Technologies
Motilal Oswal has given a ‘Buy’ call on the stock of HCL Technologies with a target price of Rs 2,200. The company’s management pressed on the fact that deal durations are shortening, with larger deals being broken into smaller chunks. However, the pipeline remains strong and deal momentum is improving. “While near-term uncertainty remains, HCLT’s growth quality is strong. We estimate 6.5% YoY growth in constant currency for FY26e; a softer Q3 has tempered expectations for Q4. A stronger discretionary spending environment could present an upside risk to these numbers,” said Motilal Oswal Financial Services.
Endurance Technologies
Endurance Tech is the top pick of Motilal Oswal in the auto-ancillary segment. They reiterated the ‘Buy’ call with a target price of Rs 2,400. The brokerage is optimistic about the company’s strategic push to the 4-wheeler segment, targeting 45% of sales by FY30. “A steady recovery in 2W demand, an expanding presence in PVs, and a robust EU order backlog serve as key growth drivers,” added the brokerage firm.
IIFL Finance
Motilal Oswal gave a ‘Buy’ rating to IIFL Finance on the back of strong growth in its gold loan portfolio. It grew 40% sequentially. “IIFL’s management shared that with the embargo on the gold lending business now lifted, the company is well-positioned for the next phase of high-quality growth in secured products like gold loans and LAP,” said the brokerage firm. Gold prices have been firming up in recent times and are trading near all-time highs.
ALSO READ4 reasons Jefferies has Buy on Bharti Airtel Ipca Laboratories
The brokerage house has a ‘Buy’ call on Ipca Laboratories, with a target price of Rs 1,940. It raised the earnings estimates to 4% for FY25, 3% for FY26, 2% for FY27. The reasoning was an increased share of higher margin products, better operating leverage for the US business, and a revival in the South African business. “IPCA remains on track to: a) revive the US business from its own site as well as integrate/scale Unichem operations, b) increase offerings/enhance reach/gain market share in the DF segment,
» Read More
